反应详情

A suspension of 5-chloropyrimidin-2-one (392 mg) and 5-bromoacetyl-4-methylthiazole (660 mg) in dry dichloromethane was treated with triethylamine (0.42 ml) and the resulting pale yellow solution was stirred at room temperature. After 1.25 h a precipitate had formed and the mixture was cooled in an ice-bath. The solid was collected, washed with cold dichloromethane and dried (346 mg). A second crop was obtained by concentration of the mother liquors (255 mg). The combined solids were recrystallised from acetone and then dichloromethane to give white crystals, the title pyrimidinone (186 mg) m.p. 212°-215° C. λmax (EtOH) 250.5 nm (E1cm1% 403), 266.5 nm (E1cm1% 401), 334 nm (E1cm1% 65). High performance liquid chromatography (reverse phase column, acetonitrilewater, 1:3) showed only one major component. N.M.R. (DMSO d6): 0.68 (2'-H), 1.28, 1.54 (two doublets, J 4 Hz) (4,6-H), 4.69 (--CH2 --), 7.21 τ (4' -CH3).

1. customAfter 1.25 h a precipitate had formed
2. temperaturethe mixture was cooled in an ice-bath
3. customThe solid was collected
4. washwashed with cold dichloromethane
5. customdried (346 mg)
6. customA second crop was obtained by concentration of the mother liquors (255 mg)
7. customThe combined solids were recrystallised from acetone
8. customdichloromethane to give white crystals